KONEXApparel & Living227420

Dobu

₩840▼ 1.06%2026-11-18 close
Market Cap
₩32B
Turnover
₩291,806
Volume
404 shares
Shares out.
38M
PER
—
PBR
—
EPS
—
Dividend Yield
—

PER, PBR and dividend yield are calculated from the latest confirmed results (EPS, BPS, dividend per share) and the current share price · Prices as of the 2026-11-18 close

01

Report overview

Respirator maker still posting losses

Dobu, a maker of industrial and disaster-response respirators, recorded operating and net losses for fiscal 2025, and its thin equity leaves limited financial cushion.

  1. 1

    On a standalone basis for fiscal 2025 (19th term), revenue was KRW 16,451 million, with an operating loss of KRW 148 million and a net loss of KRW 220 million.

  2. 2

    On the same basis, total equity stood at KRW 623 million against total liabilities of KRW 11,127 million, a thin capital base relative to debt.

  3. 3

    According to FnGuide data, operating profit turned into a loss in the 2024 settlement and the net loss widened.

  4. 4

    On March 27, 2026, the annual general meeting approved the financial statements and the election of a new inside director.

  5. 5

    The share price, at KRW 789 on March 27, 2026, stood at KRW 717 as of the morning of November 11, 2026, and the stock is relatively volatile for a KONEX listing.

02

Business structure

Dobu was founded in February 2007 and listed on the KONEX market in December 2016 as a respirator manufacturer. Its core line is industrial dust and gas respirators that protect workers' airways at industrial sites.

Chemical, biological and radiological protective masks and emergency evacuation masks for fires and toxic gas incidents extend the range. The company also reportedly manufactures and distributes health-use masks, so its portfolio mixes industrial and everyday or public-health uses.

The company says its product lines are certified under the Industrial Safety and Health Act. Beyond domestic manufacturing and distribution, it reportedly supplies parts of Asia through export channels. Revenue share by segment has not been confirmed, so the profit contribution of each product line is hard to gauge.

In competition, the company is grouped with peers such as Deopyeonhan Yangju, Ecoglow and G&E Healthcare in masks and hygiene products. The company website traces its origins to industrial dust-mask development in the 1970s and highlights filter performance and design as strengths.

A blockchain business push was reported in 2019, but the company now presents mask manufacturing and distribution as its center. On November 7, 2025, it took part in the KRX KONEX joint investor relations event and explained its industrial and chemical-protection mask products.

03

Recent trends

According to the fiscal 2025 (19th term) financial statements disclosed on March 27, 2026, standalone revenue was KRW 16,451 million. On the same basis, the operating loss was KRW 148 million and the net loss was KRW 220 million.

On a consolidated basis, the operating loss was KRW 157 million and the net loss KRW 229 million, and the auditor issued a clean opinion for both standalone and consolidated statements.

The same statements show total assets of KRW 11,750 million, total liabilities of KRW 11,127 million and total equity of KRW 623 million. Liabilities are more than 17 times equity, so the financial cushion is thin.

According to FnGuide, standalone revenue rose 2.6% in the 2024 settlement, but operating profit turned into a loss. The same data show the net loss widened sharply from the prior year. The share price was KRW 789 at 16:10 on March 27, 2026, down 1.25% on the day.

TradingView data show a one-year return of -56.53% and annual volatility of 34.56%. As of the morning of November 11, 2026, the share price stood at KRW 717, up 13.09% from the previous day.

04

Outlook

The first point to watch is whether the losses seen in fiscal 2025 continue after 2026. A change to the appointed sponsor agreement was disclosed on June 22, 2026, and an investor relations event was disclosed on September 17, 2026.

At its November 2025 IR, the company said it would continue discussions on investment cooperation and overseas channel expansion, and that overseas expansion is still at the discussion stage.

At the same IR, the company and investors discussed supply-chain security for disaster-response equipment and how rising safety awareness could change the market. With total equity at roughly KRW 623 million, a continued loss would likely show up quickly in the capital structure and financial ratios.

The next checkpoint is whether the operating results in the third-quarter 2026 quarterly report show the losses continuing. The division of duties of the newly elected inside director, Park Hyung-min, is also a signal of management direction.

Demand for industrial safety and disaster-response products depends on how often emergencies occur and on the level of safety awareness.

05

Bull factors

Industrial and disaster-response demand

Dobu says its product lines are certified under the Industrial Safety and Health Act. At the IR event, director Im Hyun-su explained that respirators are used in emergencies, so performance and reliability matter most.

The range from industrial dust and gas masks to chemical-protection masks and emergency evacuation hoods can address both industrial and disaster-response demand.

Overseas channel expansion talks

Beyond domestic sales, Dobu reportedly supplies parts of Asia through export channels. The company said it plans to keep discussing investment cooperation and overseas channel expansion after its November 2025 IR.

Its company history records an October 2020 export of its Dobu 700 product to Ireland's health authority, showing prior overseas supply experience.

Breadth of product portfolio

The company website presents industrial dust and gas masks, chemical-protection masks, emergency evacuation masks and health-use masks together. The company claims its filter types and performance are world-class and cites design and convenience as competitive points.

Covering both industrial and everyday or public-health uses can spread exposure to demand swings in any one segment.

06

Bear factors

Continued losses and thin equity

Standalone operating loss for the 19th term was KRW 148 million and the net loss KRW 220 million, so losses continued. Equity of KRW 623 million is small against liabilities of KRW 11,127 million, indicating heavy reliance on debt.

Since operating profit turned into a loss in 2024, the sustainability of any improvement in profitability is the key issue.

Share price volatility and thin trading

According to TradingView data, the share price volatility stands at 34.56%, which is high. The one-year return was -56.53%, and the share price moved from KRW 789 on March 27, 2026 to KRW 717 on the morning of November 11, 2026. As a KONEX-listed stock with small trading value, the price can move sharply on a limited number of trades.

Uncertainty in overseas sales and business direction

Overseas channel expansion is presented as a discussion stage, so the timing of any contribution to results is not set. A 2019 blockchain business push was reported, which could be cited as evidence that the business focus has shifted before.

Masks remain the core business, but the scale of exports and segment profitability are limited in disclosed data.

07

Risk factors

Financial

Standalone liabilities of KRW 11,127 million are more than 17 times the KRW 623 million of equity for the 19th term. Under this structure, continued operating losses could reduce equity quickly. Consolidated equity was reported at KRW 325 million, so the buffer is limited.

Market

KONEX stocks often trade thinly, which can produce large price swings. According to TradingView data, annual volatility is 34.56%. Short-term flows and a few trades can move the price, so the share price may diverge from business results.

Regulatory and macro

The company's product lines depend on certification under the Industrial Safety and Health Act. Changes to certification standards or safety rules could affect both certification costs and demand. Macro factors such as industrial investment flows and disaster-response budgets could also affect demand for respirators.

08

Overall view

Dobu is a KONEX-listed maker of industrial and disaster-response respirators. Its standalone revenue for fiscal 2025 (19th term) was KRW 16,451 million, but operating and net losses continued.

A financial structure with KRW 11,127 million in liabilities against KRW 623 million in equity could weigh on financial capacity if losses persist.

On the positive side, certified product lines under the Industrial Safety and Health Act, chemical-protection and emergency evacuation product lines, and export channels to parts of Asia are cited as the business base.

On the negative side, the operating losses since 2024, the thin capital base and overseas channel expansion still at the discussion stage remain open issues.

The share price moved from KRW 789 on March 27, 2026 to KRW 717 on the morning of November 11, 2026, with a one-year return of -56.53% and annual volatility of 34.56%.

The next checkpoints are the operating profit and loss trend in the third-quarter 2026 quarterly report, the business plans presented after the IR event disclosed on September 17, 2026, and whether overseas export results are disclosed.

Taken together, the business base is intact, but whether profitability and the financial structure improve is the central variable.

09

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 9 more articles and sources
  1. digitaltoday.co.kr
  2. comp.fnguide.com
  3. dobu.co.kr
  4. erounews.kr
  5. marketbz.com
  6. tradingview.com
  7. thevc.kr
  8. prestocknews.com
  9. saramin.co.kr

Report written 2026-11-11 · Data as of 2026-11-10

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis